FDA Inspection
B & B Pharmaceuticals, Inc.B & B Pharmaceuticals, Inc. – FDA Inspection, Oct 30, 2018
Record Details
This FDA Inspection record concerns B & B Pharmaceuticals, Inc., with an inspection on October 30, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Jamie L. Dion (Issuing Officer)
View Company Profile
ID · e2b5db68-636f-4659-bc97-d033382e4b7e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1071869
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of B & B Pharmaceuticals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 11, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for B & B Pharmaceuticals, Inc.
- FDA Inspection 1110384 - 2019-11-18
- FDA Inspection 881892 - 2014-06-11
- FDA Inspection 643485 - 2010-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.